Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation

Pediatr Blood Cancer. 2021 Jan;68(1):e28577. doi: 10.1002/pbc.28577. Epub 2020 Sep 2.

Authors

Kristin N Maher¹, Elizabeth Gibson^{1

2}, Beth Boulden Warren^{1

2}, Sharon M Funk², Rick Shearer², Tyler W Buckner^{2

3}, Michael Wang^{1

2}, Marilyn J Manco-Johnson^{1

2}, Christopher J Ng^{1

2}

Affiliations

¹ Department of Pediatrics Section of Hematology, Oncology and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, Colorado.
² Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
³ Department of Medicine Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado.

PMID: 32881253
DOI: 10.1002/pbc.28577

No abstract available

Publication types

Letter
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adolescent
Child
Child, Preschool
Factor VIII / therapeutic use*
Female
Hemophilia A / drug therapy*
Hemophilia A / pathology
Hemorrhage / prevention & control*
Humans
Infant
Male
Practice Guidelines as Topic / standards*
Premedication / methods*
Primary Prevention
Prognosis
Time-to-Treatment

Substances

Factor VIII